| scholarly article | Q13442814 |
| P356 | DOI | 10.1167/IOVS.14-16186 |
| P8608 | Fatcat ID | release_pgnnugmkznfinbb4nkjt6c7ca4 |
| P932 | PMC publication ID | 4451613 |
| P698 | PubMed publication ID | 26024097 |
| P50 | author | Reza Dana | Q16206939 |
| Claus Cursiefen | Q64866716 | ||
| P2093 | author name string | Daniel R Saban | |
| Felix Bock | |||
| Deniz Hos | |||
| Nancy J Reyes | |||
| Rose Mathew | |||
| Tomas Blanco | |||
| Hyun-Soo Lee | |||
| P2860 | cites work | Intravital two-photon microscopy of immune cell dynamics in corneal lymphatic vessels | Q27316545 |
| Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis | Q28200101 | ||
| CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs | Q28594485 | ||
| Molecular regulation of angiogenesis and lymphangiogenesis | Q29616150 | ||
| Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage | Q33369958 | ||
| Cellular-level characterization of lymph vessels in live, unlabeled corneas by in vivo confocal microscopy | Q33508054 | ||
| VEGF-A expression by HSV-1-infected cells drives corneal lymphangiogenesis | Q33615188 | ||
| Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. | Q33731734 | ||
| New paradigms in type 2 immunity | Q33835435 | ||
| Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth. | Q33899627 | ||
| B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization | Q33993521 | ||
| Allergic and immunologic disorders of the eye. Part II: ocular allergy | Q34102493 | ||
| Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin | Q34136309 | ||
| New twists to an old story: novel concepts in the pathogenesis of allergic eye disease | Q34529798 | ||
| Ocular mucosal CD11b+ and CD103+ mouse dendritic cells under normal conditions and in allergic immune responses | Q34731337 | ||
| Thrombospondin 1 inhibits inflammatory lymphangiogenesis by CD36 ligation on monocytes | Q34973731 | ||
| Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision | Q34984061 | ||
| An important role of lymphatic vessel activation in limiting acute inflammation | Q34997755 | ||
| Ocular allergy modulation to hi-dose antigen sensitization is a Treg-dependent process | Q35005963 | ||
| Rapid vascular regrowth in tumors after reversal of VEGF inhibition | Q35052385 | ||
| The chemokine receptor CCR7 expressed by dendritic cells: a key player in corneal and ocular surface inflammation | Q35145988 | ||
| A novel pro-lymphangiogenic function for Th17/IL-17. | Q35525349 | ||
| The cornea has "the nerve" to encourage immune rejection | Q35664876 | ||
| The chemokine receptor CX3CR1 mediates homing of MHC class II-positive cells to the normal mouse corneal epithelium. | Q36083323 | ||
| Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung. | Q36209876 | ||
| Mast cells and eosinophils: a novel link between inflammation and angiogenesis in allergic diseases | Q36256207 | ||
| Lymphangiogenesis in development and human disease | Q36342355 | ||
| Mast cells can secrete vascular permeability factor/ vascular endothelial cell growth factor and exhibit enhanced release after immunoglobulin E-dependent upregulation of fc epsilon receptor I expression | Q36401802 | ||
| Increased lymphangiogenesis in joints of mice with inflammatory arthritis | Q36465469 | ||
| Cutting edge: lymphatic vessels, not blood vessels, primarily mediate immune rejections after transplantation | Q36497556 | ||
| Inhibition of chronic and acute skin inflammation by treatment with a vascular endothelial growth factor receptor tyrosine kinase inhibitor | Q36734939 | ||
| Blockade of prolymphangiogenic vascular endothelial growth factor C in dry eye disease | Q36776787 | ||
| Allergic conjunctivitis renders CD4(+) T cells resistant to t regulatory cells and exacerbates corneal allograft rejection | Q36807337 | ||
| The chemokine receptor CCR7 mediates corneal antigen-presenting cell trafficking. | Q37159454 | ||
| Axitinib--a selective inhibitor of the vascular endothelial growth factor (VEGF) receptor | Q37624473 | ||
| Lymphangiogenesis: Molecular mechanisms and future promise | Q37697245 | ||
| Consensus statement on indications for anti-angiogenic therapy in the management of corneal diseases associated with neovascularisation: outcome of an expert roundtable | Q37895402 | ||
| Novel anti(lymph)angiogenic treatment strategies for corneal and ocular surface diseases | Q38076645 | ||
| Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice | Q39714957 | ||
| VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment | Q40725945 | ||
| Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages | Q41887679 | ||
| Targeting lymphangiogenesis after islet transplantation prolongs islet allograft survival | Q42272995 | ||
| Sunitinib inhibits inflammatory corneal lymphangiogenesis. | Q44060628 | ||
| Improved semiautomatic method for morphometry of angiogenesis and lymphangiogenesis in corneal flatmounts | Q44226517 | ||
| Blocking CCR7 at the ocular surface impairs the pathogenic contribution of dendritic cells in allergic conjunctivitis | Q44491491 | ||
| Vascular endothelial growth factor receptor-3 mediates induction of corneal alloimmunity | Q47244359 | ||
| Induction of cutaneous delayed-type hypersensitivity reactions in VEGF-A transgenic mice results in chronic skin inflammation associated with persistent lymphatic hyperplasia | Q47726749 | ||
| Targeting lymphatic vessel activation and CCL21 production by vascular endothelial growth factor receptor-3 inhibition has novel immunomodulatory and antiarteriosclerotic effects in cardiac allografts. | Q50559921 | ||
| Critical role of CD11b+ macrophages and VEGF in inflammatory lymphangiogenesis, antigen clearance, and inflammation resolution. | Q51734752 | ||
| Chymase-positive mast cells play a role in the vascular component of airway remodeling in asthma. | Q53547680 | ||
| Neutrophils contribute to inflammatory lymphangiogenesis by increasing VEGF-A bioavailability and secreting VEGF-D. | Q54786757 | ||
| Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis | Q57382204 | ||
| A model of angiogenesis in the mouse cornea | Q71174063 | ||
| Lymphatic vessels in the colonic mucosa in ulcerative colitis | Q73825023 | ||
| Gene expression of vascular endothelial growth factor and its receptors and angiogenesis in bronchial asthma | Q73993463 | ||
| Vascular endothelial growth factor in patients with acute asthma | Q73993508 | ||
| Simultaneous measurement of six cytokines in a single sample of human tears using microparticle-based flow cytometry: allergics vs. non-allergics | Q74019442 | ||
| Lymphangiogenesis in COPD: another link in the pathogenesis of the disease | Q82872231 | ||
| The effect of perioperative allergic conjunctivitis on corneal lymphangiogenesis after corneal transplantation | Q84303221 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | eye disease | Q3041498 |
| lymphangiogenesis | Q6708231 | ||
| P304 | page(s) | 3140-3148 | |
| P577 | publication date | 2015-05-01 | |
| P1433 | published in | Investigative Ophthalmology Visual Science | Q6060707 |
| P1476 | title | Involvement of corneal lymphangiogenesis in a mouse model of allergic eye disease | |
| P478 | volume | 56 |
| Q47759308 | Angiogenesis and lymphangiogenesis in corneal transplantation-A review |
| Q83228071 | Complement and CD4 T cells drive context-specific corneal sensory neuropathy |
| Q47266557 | Corneal Neovascularization: A Combined Approach of Bevacizumab and Suramin Showed Increased Antiangiogenic Effect Through Downregulation of BFGF and P2X2. |
| Q64097915 | Corneal lymphangiogenesis ameliorates corneal inflammation and edema in late stage of bacterial keratitis |
| Q47940254 | Exploiting lymphatic vessels for immunomodulation: Rationale, opportunities, and challenges. |
| Q41633824 | Limited versus total epithelial debridement ocular surface injury: Live fluorescence imaging of hemangiogenesis and lymphangiogenesis in Prox1-GFP/Flk1::Myr-mCherry mice |
| Q38563744 | Linking immune responses with fibrosis in allergic eye disease |
| Q64889532 | Neutrophils cause obstruction of eyelid sebaceous glands in inflammatory eye disease in mice. |
| Q39202010 | New insights into mononuclear phagocyte biology from the visual system |
| Q36799205 | Pathological lymphangiogenesis is modulated by galectin-8-dependent crosstalk between podoplanin and integrin-associated VEGFR-3. |
| Q61445581 | Phase-specific functions of macrophages determine injury-mediated corneal hem- and lymphangiogenesis |
| Q50419857 | Potential lymphangiogenesis therapies: Learning from current antiangiogenesis therapies-A review. |
| Q57048591 | Resolvin D1 treatment on goblet cell mucin and immune responses in the chronic allergic eye disease (AED) model |
| Q92918329 | TGFBIp mediates lymphatic sprouting in corneal lymphangiogenesis |
| Q41244028 | Transient Ingrowth of Lymphatic Vessels into the Physiologically Avascular Cornea Regulates Corneal Edema and Transparency |
| Q64106481 | Translational Preclinical Pharmacologic Disease Models for Ophthalmic Drug Development |
| Q36808641 | Understanding lymphangiogenesis in knockout models, the cornea, and ocular diseases for the development of therapeutic interventions. |
Search more.